| __timestamp | Amphastar Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 580415000 |
| Thursday, January 1, 2015 | 251519000 | 1032336000 |
| Friday, January 1, 2016 | 255165000 | 1702177000 |
| Sunday, January 1, 2017 | 240175000 | 2488652000 |
| Monday, January 1, 2018 | 294666000 | 3047597000 |
| Tuesday, January 1, 2019 | 322357000 | 4162821000 |
| Wednesday, January 1, 2020 | 349846000 | 6205683000 |
| Friday, January 1, 2021 | 437768000 | 7574400000 |
| Saturday, January 1, 2022 | 498987000 | 8930700000 |
| Sunday, January 1, 2023 | 644395000 | 9869200000 |
| Monday, January 1, 2024 | 11020100000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Vertex Pharmaceuticals Incorporated has consistently outperformed Amphastar Pharmaceuticals, Inc. in terms of yearly revenue. Starting in 2014, Vertex's revenue was nearly three times that of Amphastar, and by 2023, it had grown to over 15 times more. This remarkable growth trajectory highlights Vertex's strategic advancements and market positioning.
From 2014 to 2023, Vertex's revenue surged by approximately 1,600%, while Amphastar's increased by around 200%. This stark contrast underscores Vertex's dominance in the sector. The data reveals a consistent upward trend for both companies, but Vertex's ability to scale at a much faster rate is evident. As the pharmaceutical industry continues to evolve, these insights provide a glimpse into the strategic maneuvers that define market leaders.
Revenue Insights: AstraZeneca PLC and Amphastar Pharmaceuticals, Inc. Performance Compared
Sanofi and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Vertex Pharmaceuticals Incorporated vs Alnylam Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Corcept Therapeutics Incorporated
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Perrigo Company plc
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Veracyte, Inc.
Vertex Pharmaceuticals Incorporated vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics
BioMarin Pharmaceutical Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Pharming Group N.V. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Lantheus Holdings, Inc. or Amphastar Pharmaceuticals, Inc.
Revenue Insights: Alkermes plc and Amphastar Pharmaceuticals, Inc. Performance Compared
Annual Revenue Comparison: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.